peptides6155.com › Info › Regulatory Status And Detection Context — Deep Dive

Regulatory Status And Detection Context — Deep Dive

By Editorial Desk · published 2026-01-21 · last reviewed 2026-02-04 · Info

If you have been reading about Anti-doping testing and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2026-02-04. Numbers and descriptions here follow the published literature rather than marketing material.

Regulatory Status and Detection Context

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

Identity and Regulatory Status

Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.

Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.

Cardarine at a glance

PropertyValueNotes
Regulatory statusNot approved for human therapeutic useNo marketing authorization identified in major jurisdictions.
Anti-doping classPPARδ agonist; hormone and metabolic modulatorsListed on the WADA Prohibited List.
Common test matrixUrineAlso blood and tissue in research settings.
Typical analytical methodLC-MS/MSTargets parent compound and metabolites.
Major safety signalTumor findings in rodentsHuman relevance not established; limited human data.

Preclinical Findings and Safety Signals

Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.

Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.

Related pages on this site

Detection, Stability, and Quality

Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.

Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.

Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.

Further detail

18 Poems, The Sunday Referee; Parton Bookshop, 1934 Portrait of the Artist as a Young Dog, London: Dent, 1940 Deaths and Entrances, London: Dent, 1946 A Child's Christmas in Wales, New Directions, 1955 The Collected Poems of Dylan Thomas: The New Centenary Edition. Ed. with Introduction and annotations by John Goodby. London: Weidenfeld & Nicolson, 2014 The Notebook Poems 1930–34, ed. Ralph Maud. London: Dent, 1989 Dylan Thomas: The Broadcasts, ed. Ralph Maud. London: Dent, 1991 Dylan Thomas: The Filmscripts, ed. John Ackerman. London: Dent, 1995 Dylan Thomas: Early Prose Writings, ed. Walford Davies. London: Dent, 1971 Collected Stories, ed. Walford Davies. London: Dent, 1983 Under Milk Wood: A Play for Voices, ed. Walford Davies and Ralph Maud. London: Dent, 1995 On the Air with Dylan Thomas: The Broadcasts, ed. R. Maud. New York: New Directions, 1991

For the following year, Ubayd Allah was bogged down in battles with the Qaysi tribes of Jazira led by Zufar ibn al-Harith al-Kilabi. By 686, Ubayd Allah's army numbered some 60,000 troops. By the time Ubayd Allah's army approached Mosul toward Iraq, the Zubayrids under Mus'ab ibn al-Zubayr had established themselves in Basra while al-Mukhtar ibn Abi Ubayd took control of Kufa in the name of the Alid Muhammad ibn al-Hanafiyya. Al-Mukhtar dispatched Ibrahim ibn al-Ashtar and an army composed largely of non-Arab freedmen to confront Ubayd Allah. The latter fended off the first wave of al-Mukhtar's troops, and proceeded to face off Ibn al-Ashtar at the Khazir River. In the ensuing Battle of Khazir, the Umayyad army was routed and Ubayd Allah was slain by Ibn al-Ashtar. His lieutenants Husayn, Shurahbil and al-Rabi'a were also killed. With Ubayd Allah's death, Caliph Abd al-Malik halted further advances against Iraq until 691.

== Preparation and reactions == DNCB is produced commercially by the nitration of p-nitrochlorobenzene with a mixture of nitric and sulfuric acids. Other methods afford the compound less efficiently include the chlorination of 1,3-dinitrobenzene, nitration of o-nitrochlorobenzene and the dinitration of chlorobenzene. By virtue of the two nitro substituents, the chloride in DNCB is particularly susceptible to nucleophilic substitution, at least relative to simple chlorobenzene. In this way, the compound is a precursor to many other compounds. For example, the chloride can be replaced by iodide easily. Reaction of DNCB with ammonia gives 2,4-dinitrochloroaniline, again a versatile precursor. DNCB is as a substrate in glutathione S-transferase, relevant to activity assays.

Sources: en.wikipedia.org

Background from the literature

== Use and effects == In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDDMA's dose as greater than 150 mg orally and its duration as unknown. Findings on the effects of MDDMA are very mixed. In two reports, with 150 mg and 1,000 mg both orally, no effects whatsoever occurred. In another report, 550 mg orally resulted in very negative effects. Finally, two people who used 200 mg orally found that it produced very pleasant effects for 20 minutes, wore off, but then resurged to produce even stronger effects 4 hours later. The higher-dose reports were communicated to Shulgin anonymously and he was uncertain whether the actual substance employed was indeed MDDMA. More research seems necessary to characterize MDDMA, but Shulgin expected that a "pretty hefty dose" would be required for it to produce effects.

June 23 – COVID-19 pandemic – Washington reports their first case of the Lineage P.1 Gamma variant in an unvaccinated Clallam County resident who traveled out of the state. June 24 Surfside condominium building collapse – A 12-story condominium apartment building in Surfside, Florida partially collapses. At the official end of search on July 23, the death toll is 97, with one further person unaccounted for. A pedestrian bridge on Interstate 295 collapses in northeastern Washington, D.C., injuring five. Infrastructure policy of the Joe Biden administration: President Biden announces that he has reached a bipartisan infrastructure deal with Senators. Aftermath of the January 6 United States Capitol attack – Over 500 suspects have been arrested since the Capitol riot. U.S. Attorney General Merrick Garland announces that the first suspect is arrested for assaulting media during the events of January 6. The Appellate Division of the New York Supreme Court suspends former New York City Mayor Rudy Giuliani from practicing law over his false claims about the 2020 election. Microsoft unveils Windows 11, the latest generation of its computer operating system. The Federal Aviation Administration approves a request to rename McCarran International Airport in Las Vegas, currently the seventh-busiest airport by passenger traffic in the United States, to Harry Reid International Airport. June 25 Defending Stanley Cup champion Tampa Bay Lightning advance to the Stanley Cup Finals to face the Montreal Canadiens.

By starting from a weaker mobile phase and strengthening it during the runtime, gradient elution decreases the retention of the later-eluting components so that they elute faster, giving narrower (and taller) peaks for most components, while also allowing for the adequate separation of earlier-eluting components. This also improves the peak shape for tailed peaks, as the increasing concentration of the organic eluent pushes the tailing part of a peak forward. This also increases the peak height (the peak looks "sharper"), which is important in trace analysis. The gradient program may include sudden "step" increases in the percentage of the organic component, or different slopes at different times – all according to the desire for optimum separation in minimum time. In isocratic elution, the retention order does not change if the column dimensions (length and inner diameter) change – that is, the peaks elute in the same order. In gradient elution, however, the elution order may change as the dimensions or flow rate change. if they are no scaled down or up according to the change The driving force in reversed phase chromatography originates in the high order of the water structure. The role of the organic component of the mobile phase is to reduce this high order and thus reduce the retarding strength of the aqueous component.

=== Pharmacokinetics === Paroxetine is well-absorbed following oral administration. It has an absolute bioavailability of about 50%, with evidence of a saturable first pass effect. When taken orally, it achieves maximum concentration in about 6–10 hours and reaches steady-state in 7–14 days. Paroxetine exhibits significant interindividual variations in volume of distribution and clearance. Less than 2% of an oral dose is excreted in urine unchanged. Paroxetine is a mechanism-based inhibitor of CYP2D6.

Sources: en.wikipedia.org

Further detail

Britain had 750,000 men under arms between 1792 and 1815 as its army expanded from 40,000 men in 1793 to a peak of 250,000 men in 1813. Over 250,000 sailors served in the Royal Navy. In September 1812, Russia had 900,000 enlisted men in its army, and between 1799 and 1815 2.1 million men served in its army. Another 200,000 served in the Imperial Russian Navy. Out of the 900,000 men, the field armies deployed against France numbered less than 250,000. There are no consistent statistics for other major combatants. Austria's forces peaked at about 576,000 (during the War of the Sixth Coalition) and had little or no naval component yet never fielded more than 250,000 men in field armies. After Britain, Austria proved the most persistent enemy of France; more than a million Austrians served during the long wars. Its large army was overall quite homogeneous and solid and in 1813 operated in Germany (140,000 men), Italy and the Balkans (90,000 men at its peak, about 50,000 men during most of the campaigning on these fronts). Austria's manpower was becoming quite limited towards the end of the wars, leading its generals to favour cautious and conservative strategies, to limit their losses.

Pyroglutamate aminopeptidase is a type of enzyme that cleaves the peptide bond linking the N-terminal end of a polypeptide forming a cyclical lactam to the next amino acid residue. This cyclic structure protects the polypeptide from degradation but renders the protein difficult to analyze in the laboratory. Pyroglutamate aminopeptidase may be used to cleave the cyclical lactam and will therefore leave the next amino acid with a free N-terminal.

== See also == Thomas Graham (chemist), the founder of dialysis and father of colloid chemistry Dialysis tubing List of dialysis providers in the United States Vitamin and mineral management for dialysis Nephrology Hepatorenal syndrome

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine approved for any medical use?

No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.

Why is cardarine prohibited in sport?

It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.

What is known about cardarine and cancer?

Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.

Is cardarine a SARM?

No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.

Network